MedPath

Superficial Cryotherapy Versus Microneedling in Alopecia Areata

Not Applicable
Completed
Conditions
Alopecia Areata
Interventions
Procedure: DMEP kit
Device: Dermapen
Registration Number
NCT04680234
Lead Sponsor
Sohag University
Brief Summary

This study is randomized comparative analytical prospective study that included patients with mild and moderate alopecia areata. Patients was divided into two groups Patients in the first group underwent Superficial cryotherapy using dimethyl ether and propane (DMEP) at -57C (Cryotherapy group). Patients in the second group underwent Microneedling (Microneedling group). A total of six sessions were done at 2 weeks interval. Patients were followed-up for next 3 months to evaluate the persistence of hair regrowth after therapy. Patients were assessed at baseline and during follow up using photography, Dermoscopy, SALT score and regrowth scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • ِAlopecia areata patients
Exclusion Criteria
  • Alopecia totalis and universalis
  • ِAge less than four years.
  • ِPregnancy or breast-feeding.
  • ِActive infection at the site alopecia patch(s).
  • ِInflammation ate site of the alopecia patches
  • ِIntolerance to cold.
  • ِAssociated systemic illness such as thyroid, pernicious anaemia, diabetes mellitus, autoimmune connective tissue diseases.
  • ِPrevious treatment for alopecia areata over the last three months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cryotherapy groupDMEP kitPatients underwent superficial cryotherapy using dimethyl ether and propane (DMEP) at -57C very 2 weeks for maximum six sessions
Microneedling groupDermapenPatients underwent microneedling 2 weeks for maximum six sessions
Primary Outcome Measures
NameTimeMethod
Regrowth ScaleChange in regrowth scale from baseline to 3 months follow after end of sessions

0 score (regrowth \< 10%) no response

1. score (regrowth 11-25%) poor response

2. score (regrowth 26-50%) fair response

3. score (regrowth 51-75%) satisfactory response

4. score (regrowth ≥ 75%) excellent response.

Secondary Outcome Measures
NameTimeMethod
SALT scoreChange in salt score from baseline to 3 months follow after end of sessions

SALT score is the sum of the percentage of hair loss in all the abovementioned areas. For example, if the percentage hair loss in vertex, right profile, left profile, and posterior aspect is 20, 30, 40, and 50% respectively; then, SALT score = (20 × 0.4) = (30 × 0.18) + (40 × 0.18) + (50 × 0.24) = 8 + 5.4 + 7.2 + 12 = 32.6.

Trial Locations

Locations (1)

Sohag Faculty of Medicine

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath